Latest AI and machine learning research in other cancers for healthcare professionals.
Type 2 diabetes mellitus (T2DM) is a global health priority, with an estimated 629 million people pr...
This study evaluates the potential of oral rinse-derived and plasma circulating tumour DNA (ctDNA) i...
The liver exhibits extensive circadian regulation among organs. Epidemiological studies have substan...
OBJECTIVE: To evaluate the diagnostic performance of artificial intelligence (AI) in detecting oral ...
INTRODUCTION: Melanoma is a highly aggressive skin cancer that accounts for a disproportionate numbe...
PURPOSE: This study aimed to evaluate radiomic models' ability to predict hypoxia-related biomarker ...
PURPOSE: Uterine sarcoma is a rare disease whose association with body composition parameters is poo...
The evaluation of bone marrow pathology is essential for diagnosing and classifying myeloproliferati...
BACKGROUND: Nasopharyngeal carcinoma (NPC) lacks biomarkers demonstrating both high specificity and ...
Background and study aims Prophylactic total gastrectomy (PTG) is the definitive treatment for hered...
This investigation examined the factors involved in predicting the responses of micrometastases to t...
Hepatocellular carcinoma (HCC) is a malignant tumor with high incidence and mortality rates globally...
BackgroundPatients in palliative care often experience prolonged hospital stays, requiring detailed ...
Extrachromosomal circular DNA (eccDNA) may contribute to genomic rearrangements and tumor heterogene...
Targeted combined immunotherapy (TCI) has shown certain antitumor effects in patients with unresect...
As a highly prevalent tumor in males, prostate cancer (PCa) needs newly developed biomarkers to gui...
INTRODUCTION: Lung neuroendocrine carcinomas (Lu-NECs) are rare, highly aggressive lung tumors with ...
BACKGROUND: Next-generation sequencing (NGS) has become a cornerstone of treatment for lung cancer a...
PURPOSE: The choice of wound closure modality after limb-sparing extremity soft-tissue sarcoma (eSTS...
PURPOSE: With increasing use of human epithelial growth factor receptor two (HER2)-targeted therapie...
Early identification and referral of inflammatory breast cancer (IBC) remains challenging within lar...